Armistice Capital, LLC Pds Biotechnology Corp Transaction History
Armistice Capital, LLC
- $6.56 Billion
- Q1 2025
A detailed history of Armistice Capital, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Armistice Capital, LLC holds 4,419,000 shares of PDSB stock, worth $5.66 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,419,000Holding current value
$5.66 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
55Shares Held
8.24MCall Options Held
151KPut Options Held
1.2K-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.93 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$623,3170.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$560,4870.0% of portfolio
-
Blair William & CO Chicago, IL257KShares$329,2160.0% of portfolio
-
Ubs Group Ag251KShares$321,4790.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $36.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...